STELLARIS PHARMACEUTICALS ApS: Financial statements 2025
CVR: 34708215
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
STELLARIS PHARMACEUTICALS ApS (CVR 34708215) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -475,262 and a net result of DKK -594,882 compared with DKK -486,941 the year before. Equity in the 2025 report amounted to DKK -3,565,816. The company had 1 employee in the financial year.
- Gross Profit
- DKK -475,262
- Profit/Loss
- DKK -594,882
- Equity
- DKK -3,565,816
- Total Assets
- DKK 1,295,962
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -475 t. | -595 t. | -3.6 mio. | 1 |
| 2024 | - | -336 t. | -487 t. | -3 mio. | 1 |
| 2023 | - | -256 t. | -803 t. | -2.5 mio. | 1 |
| 2022 | - | -162 t. | -786 t. | -1.7 mio. | 1 |
| 2021 | - | -102 t. | -539 t. | -895 t. | 1 |
Official annual report
How creditworthy is STELLARIS PHARMACEUTICALS ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
STELLARIS PHARMACEUTICALS ApS has published its annual report for 2024. Gross profit came to DKK -336,355, and the net result was DKK -486,941.
About STELLARIS PHARMACEUTICALS ApS
STELLARIS PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2012. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Birgit Ter-Borch Gram Lilienfeldt Schjoldager. The company is owned by Ranoda Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -475,262 and a net result of DKK -594,882 compared with DKK -486,941 the year before. Equity in the 2025 report amounted to DKK -3,565,816.